LINDAHL RICHARD S 内部人交易：近期 SEC Form 4 交易
过去 18 个月，LINDAHL RICHARD S（CIK 1196632）在 1 家公司共报告 8 笔 SEC Form 4 内部人交易（最近一笔 2026-06-10）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-10 | Emergent BioSolutions Inc. (EBS) | EVP, Chief Financial Officer | 卖出 | 3,964 | $31,712 |
| 2026-05-01 | Emergent BioSolutions Inc. (EBS) | EVP, Chief Financial Officer | 买入 | 162,680 | $0 |
| 2026-03-05 | Emergent BioSolutions Inc. (EBS) | EVP, Chief Financial Officer | 卖出 | 23,650 | $199,606 |
| 2026-03-03 | Emergent BioSolutions Inc. (EBS) | EVP, Chief Financial Officer | 卖出 | 683 | $5,566 |
| 2026-02-10 | Emergent BioSolutions Inc. (EBS) | EVP, Chief Financial Officer | 卖出 | 46,155 | $504,013 |
| 2026-02-10 | Emergent BioSolutions Inc. (EBS) | EVP, Chief Financial Officer | 卖出 | 5,642 | $61,611 |
| 2025-10-17 | Emergent BioSolutions Inc. (EBS) | EVP, Chief Financial Officer | 卖出 | 4,995 | $47,952 |
| 2025-06-10 | Emergent BioSolutions Inc. (EBS) | EVP, Chief Financial Officer | 卖出 | 2,733 | $18,120 |
来源：SEC Form 4 申报文件 · 截至 2026-06-10